Kosin Medical Journal (Jun 2024)

Treatment of pediatric obstructive sleep apnea

  • Tae Kyung Koh,
  • Jooyeon Kim

DOI
https://doi.org/10.7180/kmj.24.120
Journal volume & issue
Vol. 39, no. 2
pp. 89 – 93

Abstract

Read online

In the majority of cases, pediatric obstructive sleep apnea (OSA) is associated with adenotonsillar hypertrophy. Therefore, adenotonsillectomy is typically considered as the first line of treatment. However, the severity of pediatric OSA is not always directly correlated with the size of the adenoids and tonsils. Other factors, such as upper airway anatomy or obesity, may interact in a multifactorial manner to contribute to its occurrence. For these reasons, sleep apnea in obese children may resemble the condition in adults. Furthermore, in these cases, if adenotonsillar hypertrophy is present, adenotonsillectomy is likely to be prioritized. Reevaluation should be conducted 6 to 8 weeks post-surgery, and additional treatment for residual sleep apnea should be performed thereafter when necessary.

Keywords